Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Genitourinary 1

Conditions

Breast Neoplasms 485Carcinoma, Non-Small-Cell Lung 440Prostatic Neoplasms 292Lung Neoplasms 170Stomach Neoplasms 140Neoplasms 114Squamous Cell Carcinoma of Head and Neck 110Neoplasm Metastasis 98Head and Neck Neoplasms 97Esophageal Neoplasms 71Ovarian Neoplasms 57Pancreatic Neoplasms 42Urinary Bladder Neoplasms 39Sarcoma 39Nasopharyngeal Carcinoma 36Carcinoma, Squamous Cell 30Triple Negative Breast Neoplasms 28Carcinoma, Ovarian Epithelial 28Adenocarcinoma of Lung 27Adenocarcinoma 27Esophageal Squamous Cell Carcinoma 26Parkinson Disease 4, Autosomal Dominant Lewy Body 23Carcinoma, Transitional Cell 23Adenocarcinoma Of Esophagus 23Breast Neoplasms, Male 22Recurrence 21Unspecified Adult Solid Tumor, Protocol Specific 20Inflammatory Breast Neoplasms 20Fallopian Tube Neoplasms 20Melanoma 18

Interventions

Cisplatin 12Etoposide 11Carboplatin 9Paclitaxel 7Ifosfamide 7Filgrastim 7Bleomycin 6Radiotherapy 5Magnetic Resonance Spectroscopy 4pegfilgrastim 3Peripheral Blood Stem Cell Transplantation 3liposomal amphotericin B 2Therapeutics 2Platinum 2Ipilimumab 2Imatinib Mesylate 2Granulocyte Colony-Stimulating Factor 2Cyclophosphamide 2CTLA-4 Antigen 2tremelimumab 1sodium thiosulfate 1sargramostim 1lerisetron 1ixabepilone 1etoposide phosphate 1durvalumab 1cabozantinib 1aldesleukin 1Vinblastine 1Thiotepa 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Seminoma × Docetaxel × Clear all
NCT00002903 2012-07-02

Docetaxel in Treating Patients With Recurrent or Refractory Germ Cell Cancer

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Completed
25 enrolled
GenitourinaryGynecologic

Testicular Germ Cell Tumor, Ovarian Neoplasms, Testicular Neoplasms, Seminoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡